These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1700117)

  • 1. Acute retention of urine: is trial without catheter justified?
    Hastie KJ; Dickinson AJ; Ahmad R; Moisey CU
    J R Coll Surg Edinb; 1990 Aug; 35(4):225-7. PubMed ID: 1700117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.
    Desgrandchamps F; De La Taille A; Doublet JD;
    BJU Int; 2006 Apr; 97(4):727-33. PubMed ID: 16536763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention.
    Ghalayini IF; Al-Ghazo MA; Pickard RS
    BJU Int; 2005 Jul; 96(1):93-7. PubMed ID: 15963128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary retention in adults: diagnosis and initial management.
    Selius BA; Subedi R
    Am Fam Physician; 2008 Mar; 77(5):643-50. PubMed ID: 18350762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of treatment with tamsulosin in men with acute urinary retention.
    Kim HL; Kim JC; Benson DA; Bales GT; Gerber GS
    Tech Urol; 2001 Dec; 7(4):256-60. PubMed ID: 11763483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of acute urinary retention.
    Fitzpatrick JM; Kirby RS
    BJU Int; 2006 Apr; 97 Suppl 2():16-20; discussion 21-2. PubMed ID: 16507048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of doxazosin in the treatment of acute urinary retention due to benign prostate hyperplasia.
    Prieto L; Romero J; López C; Ortiz M; Pacheco JJ
    Urol Int; 2008; 81(1):66-71. PubMed ID: 18645274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
    J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transurethral vaporization of the prostate in the treatment of bladder outlet obstruction at two university hospitals.
    Gerber GS; Jahoda A; Bales GT; Albala DM
    Tech Urol; 1997; 3(1):25-9. PubMed ID: 9170221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Reten-World survey of the management of acute urinary retention: preliminary results.
    Emberton M; Fitzpatrick JM
    BJU Int; 2008 Mar; 101 Suppl 3():27-32. PubMed ID: 18307683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: The CLasP study.
    Gujral S; Abrams P; Donovan JL; Neal DE; Brookes ST; Chacko KN; Wright MJ; Timoney AG; Peters TJ
    J Urol; 2000 Jul; 164(1):59-64. PubMed ID: 10840425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia.
    Kellner DS; Armenakas NA; Brodherson M; Heyman J; Fracchia JA
    Urology; 2004 Oct; 64(4):703-6. PubMed ID: 15491705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostakath in urinary outflow obstruction.
    Ala-Opas M; Talja M; Tiitinen J; Hellström P; Heikkinen A; Nurmi M
    Ann Chir Gynaecol Suppl; 1993; 206():14-8. PubMed ID: 7507307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent catheterization time required after interstitial laser coagulation of the prostate.
    Nishizawa K; Kobayashi T; Mitsumori K; Watanabe J; Ogura K
    Urology; 2004 Jul; 64(1):79-83. PubMed ID: 15245940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 23-year review of the management of acute retention of urine: progressing or regressing?
    Modi P; Pleat J; Cheetham P; Senior J; Johan R; Fellows GJ
    Ann R Coll Surg Engl; 2000 Sep; 82(5):333-5. PubMed ID: 11041033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K; Lam TB
    Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia.
    Lucas MG; Stephenson TP; Nargund V
    BJU Int; 2005 Feb; 95(3):354-7. PubMed ID: 15679793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study.
    McNeill SA; Hargreave TB; Roehrborn CG;
    Urology; 2005 Jan; 65(1):83-9; discussion 89-90. PubMed ID: 15667868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate size influences the outcome after presenting with acute urinary retention.
    McNeill AS; Rizvi S; Byrne DJ
    BJU Int; 2004 Sep; 94(4):559-62. PubMed ID: 15329112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia.
    Tiong HY; Tibung MJ; Macalalag M; Li MK; Consigliere D
    Urol Int; 2009; 83(1):44-8. PubMed ID: 19641358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.